Semler Scientific Faces Critical Juncture Amid Acquisition and Bitcoin Strategy

Semler Scientific finds itself at a pivotal crossroads as the medical technology firm navigates a potential acquisition while grappling with significant stock declines. The company’s shares have plummeted more than 50% since January, creating a tense atmosphere ahead of two crucial events: quarterly earnings release and a landmark merger agreement. Investors are left wondering whether this represents a final collapse or the beginning of an unexpected recovery.

The upcoming all-stock acquisition by Strive, Inc. has fundamentally altered how Semler Scientific approaches its financial communications. In an unusual departure from standard practice, the company has decided against holding its customary earnings call alongside today’s quarterly results. This strategic shift signals that operational Read more...